TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Modulation of the Estrogen/erbB2 Receptors Cross-talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-positive Breast Cancer.

Lucia Viganò et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.